These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17522566)

  • 1. When less is more: reducing the incidence of antipsychotic polypharmacy.
    Tucker WM
    J Psychiatr Pract; 2007 May; 13(3):202-4. PubMed ID: 17522566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of concurrent antipsychotic prescribing practices through the use of PSYCKES.
    Uttaro T; Finnerty M; White T; Gaylor R; Shindelman L
    Adm Policy Ment Health; 2007 Jan; 34(1):57-61. PubMed ID: 16807792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.
    Thompson A; Sullivan SA; Barley M; Strange SO; Moore L; Rogers P; Sipos A; Harrison G
    Psychol Med; 2008 May; 38(5):705-15. PubMed ID: 17825122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of antipsychotic polypharmacy in Christchurch.
    McKean A; Vella-Brincat J
    Australas Psychiatry; 2009 Aug; 17(4):336-7. PubMed ID: 19585299
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.
    Craig TJ; Grossman S; Bromet EJ; Fochtmann LJ; Carlson GA
    Compr Psychiatry; 2007; 48(6):497-503. PubMed ID: 17954133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of web-based tools, leadership feedback, and policies on inpatient antipsychotic polypharmacy.
    Finnerty MT; Kealey E; Leckman-Westin E; Gupta N; White TM; Engel GM; Opler LA
    Psychiatr Serv; 2011 Oct; 62(10):1124-6. PubMed ID: 21969636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological treatment of psychotic conditions].
    Fink-Jensen A; Larsen JT; Nielsen B; Lublin H
    Ugeskr Laeger; 2008 Nov; 170(46):3750-3. PubMed ID: 19014721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
    Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA
    Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic polypharmacy: do benefits justify the risks?
    Tapp AM; Wood AE; Kilzieh N; Kennedy A; Raskind MA
    Ann Pharmacother; 2005 Oct; 39(10):1759-60. PubMed ID: 16144885
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic prescriptions in a university hospital outpatient population in Turkey: a retrospective database analysis, 2005-2006.
    Atik L; Erdogan A; Karaahmet E; Saracli O; Atasoy N; Kurcer MA; Balcioglu I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):968-74. PubMed ID: 18243462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.
    Hamann J; Mendel RT; Fink B; Pfeiffer H; Cohen R; Kissling W
    J Nerv Ment Dis; 2008 Apr; 196(4):329-32. PubMed ID: 18414128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity in psychiatry: its impact on psychopharmacological treatment.
    Loga S; Loga-Zec S
    Psychiatr Danub; 2009 Sep; 21(3):347-9. PubMed ID: 19794354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis.
    Nieman DH; Rike WH; Becker HE; Dingemans PM; van Amelsvoort TA; de Haan L; van der Gaag M; Denys DA; Linszen DH
    Int Clin Psychopharmacol; 2009 Jul; 24(4):223-8. PubMed ID: 19521246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macro-monitoring: a step toward rational psychopharmacotherapy.
    Chien C; Solomon K; Platek TE
    Am J Hosp Pharm; 1978 Apr; 35(4):397-402. PubMed ID: 645711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.